Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of difloxacin in sheep

被引:18
作者
Marin, P. [1 ]
Fernandez-Varon, E. [1 ]
Escudero, E. [1 ]
Carceles, C. M. [1 ]
机构
[1] Univ Murcia, Fac Vet Med, Dept Pharmacol, E-30071 Murcia, Spain
关键词
difloxacin; pharmacokinetics; sheep; bioavailability;
D O I
10.1016/j.rvsc.2007.01.005
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The disposition kinetics of difloxacin, a fluoroquinolone antibiotic, after intravenous (IV), intramuscular (IM) and subcutaneous (SQ administration were determined in sheep at a single dose of 5 mg/kg. The concentration-time data were analysed by compartmental (after IV dose) and non-compartmental pharmacokinetics method (after IV, IM and SC administration). Plasma concentrations of difloxacin were determined by high performance liquid chromatography with fluorescence detection. Steady-state volume of distribution (V-ss) and clearance (CI) of difloxacin after IV administration were 1.68 +/- 0.21 L/kg and 0.21 +/- 0.03 L/h kg, respectively. Following IM and SC administration difloxacin achieved maximum plasma concentration of 1.89 +/- 0.55 and 1.39 +/- 0.14 mg/L at 2.42 +/- 1.28 and 5.33 +/- 1.03 h, respectively. The absolute bioavailabilities after IM and SC routes were 99.92 +/- 26.50 and 82.35 +/- 25.65%, respectively. Based on these kinetic parameters, difloxacin is likely to be effective in sheep. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:234 / 238
页数:5
相关论文
共 29 条
[1]   Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural [J].
Abd El-Aty, AM ;
Goudah, A ;
Ismail, M ;
Shimoda, M .
VETERINARY RESEARCH COMMUNICATIONS, 2005, 29 (04) :297-304
[2]  
Atef M, 2002, DEUT TIERARZTL WOCH, V109, P320
[3]   COMPARISON OF DIFLOXACIN, ENOXACIN, AND CEFAZOLIN FOR THE TREATMENT OF EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
BOSCIA, JA ;
KOBASA, WD ;
KAYE, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :262-264
[4]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[5]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
[6]   Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses [J].
Fernandez-Varon, Emilio ;
Carceles, Carlos M. ;
Marin, Pedro ;
Martos, Nieves ;
Escudero, Elisa ;
Ayala, Ignacio .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2006, 67 (06) :1076-1081
[7]   Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats [J].
Fernandez-Varon, Emilio ;
Villamayor, Lucia ;
Escudero, Elisa ;
Espuny, Alberto ;
Carceles, Carlos M. .
VETERINARY JOURNAL, 2006, 172 (02) :302-307
[8]  
Gibaldi M, 1982, Pharmacokinetics, V15
[9]   DIFLOXACIN METABOLISM AND PHARMACOKINETICS IN HUMANS AFTER SINGLE ORAL DOSES [J].
GRANNEMAN, GR ;
SNYDER, KM ;
SHU, VS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :689-693
[10]  
HADDAD NS, 1985, AM J VET RES, V46, P2004